Efficacy and Safety of Rosuvastatin in the Prevention of Arterial and Venous Vascular Events and Mortality After Hip Fracture: A Multicenter Randomised, Double-blinded, Placebo Controlled Trial.

Trial Profile

Efficacy and Safety of Rosuvastatin in the Prevention of Arterial and Venous Vascular Events and Mortality After Hip Fracture: A Multicenter Randomised, Double-blinded, Placebo Controlled Trial.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 19 Sep 2012

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
  • Focus Therapeutic Use
  • Acronyms STAFF
  • Most Recent Events

    • 01 Sep 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 06 Apr 2012 Planned End Date changed from 1 Mar 2014 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 06 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top